Page last updated: 2024-11-04

sulfamethoxazole and Cardiac Hypertrophy

sulfamethoxazole has been researched along with Cardiac Hypertrophy in 1 studies

Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.

Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McGeady, SJ1
Murphey, SA1

Other Studies

1 other study available for sulfamethoxazole and Cardiac Hypertrophy

ArticleYear
Disseminated Mycobacterium kansasii infection.
    Clinical immunology and immunopathology, 1981, Volume: 20, Issue:1

    Topics: Cardiomegaly; Child, Preschool; Disseminated Intravascular Coagulation; Heart Failure; Humans; Immun

1981